Elevated serum hRNase 1 binds to EphA4 and triggers EphA4 signaling in an autocrine/paracrine manner, which in turn promotes breast cancer initiation via the IKK/NF-κB and MEK/Erk activating pathways. Here, MAP2K7 is linked to breast carcinoma.